NanoRepro AG - Asset Resilience Ratio

Latest as of June 2025: 19.19%

NanoRepro AG (NN6) has an Asset Resilience Ratio of 19.19% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See NanoRepro AG short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€7.29 Million

≈ $8.52 Million USD Cash + Short-term Investments

Total Assets

€37.99 Million

≈ $44.42 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2024)

This chart shows how NanoRepro AG's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see NanoRepro AG assets under control.

Liquid Assets Composition Over Time

This chart breaks down NanoRepro AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore NanoRepro AG (NN6) investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€7.29 Million	19.19%
Short-term Investments	€0.00	0%
Total Liquid Assets	€7.29 Million	19.19%

Asset Resilience Insights

Good Liquidity Position: NanoRepro AG maintains a healthy 19.19% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

NanoRepro AG Industry Peers by Asset Resilience Ratio

Compare NanoRepro AG's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
LONZA GROUP UNSP.ADR 1/10 F:LO3A	Diagnostics & Research	3.04%
Healius Ltd AU:HLS	Diagnostics & Research	0.06%
Eurofins-Cerep SA PA:ALECR	Diagnostics & Research	13.42%
Gencurix Inc KQ:229000	Diagnostics & Research	4.01%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for NanoRepro AG (2010–2024)

The table below shows the annual Asset Resilience Ratio data for NanoRepro AG.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	23.31%	€9.10 Million ≈ $10.64 Million	€39.03 Million ≈ $45.62 Million	-26.43pp
2023-12-31	49.74%	€20.62 Million ≈ $24.11 Million	€41.46 Million ≈ $48.47 Million	-13.44pp
2022-12-31	63.18%	€31.26 Million ≈ $36.55 Million	€49.48 Million ≈ $57.84 Million	+27.78pp
2021-12-31	35.40%	€28.02 Million ≈ $32.76 Million	€79.15 Million ≈ $92.53 Million	+24.98pp
2020-12-31	10.42%	€1.16 Million ≈ $1.36 Million	€11.17 Million ≈ $13.06 Million	-4.93pp
2019-12-31	15.35%	€737.15K ≈ $861.81K	€4.80 Million ≈ $5.62 Million	-15.13pp
2018-12-31	30.48%	€1.77 Million ≈ $2.07 Million	€5.81 Million ≈ $6.79 Million	+17.90pp
2017-12-31	12.58%	€528.05K ≈ $617.35K	€4.20 Million ≈ $4.91 Million	-2.51pp
2016-12-31	15.09%	€530.12K ≈ $619.77K	€3.51 Million ≈ $4.11 Million	+14.98pp
2010-12-31	0.11%	€2.15K ≈ $2.52K	€1.94 Million ≈ $2.27 Million	--

pp = percentage points

About NanoRepro AG

XETRA:NN6 Germany Diagnostics & Research

Market Cap

$25.29 Million

€21.63 Million EUR

Market Cap Rank

#24435 Global

#2103 in Germany

Share Price

€1.72

Change (1 day)

+0.88%

52-Week Range

€1.38 - €2.29

All Time High

€17.14